HEADER HYDROLASE 06-MAY-17 5NWH TITLE POTENT INHIBITORS OF NUDT5 SILENCE HORMONE SIGNALING IN BREAST CANCER COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADP-SUGAR PYROPHOSPHATASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 8-OXO-DGDP PHOSPHATASE,NUCLEAR ATP-SYNTHESIS PROTEIN NUDIX5, COMPND 5 NUCLEOSIDE DIPHOSPHATE-LINKED MOIETY X MOTIF 5,HNUDT5,YSA1H; COMPND 6 EC: 3.6.1.13,3.6.1.58,2.7.7.96; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NUDT5, NUDIX5, HSPC115; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUDIX, INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.CARTER,P.STENMARK REVDAT 3 17-JAN-24 5NWH 1 REMARK REVDAT 2 16-OCT-19 5NWH 1 REMARK REVDAT 1 04-APR-18 5NWH 0 JRNL AUTH B.D.G.PAGE,N.C.K.VALERIE,R.H.G.WRIGHT,O.WALLNER,R.ISAKSSON, JRNL AUTH 2 M.CARTER,S.G.RUDD,O.LOSEVA,A.S.JEMTH,I.ALMLOF,J.FONT-MATEU, JRNL AUTH 3 S.LLONA-MINGUEZ,P.BARANCZEWSKI,F.JEPPSSON,E.HOMAN, JRNL AUTH 4 H.ALMQVIST,H.AXELSSON,S.REGMI,A.L.GUSTAVSSON,T.LUNDBACK, JRNL AUTH 5 M.SCOBIE,K.STROMBERG,P.STENMARK,M.BEATO,T.HELLEDAY JRNL TITL TARGETED NUDT5 INHIBITORS BLOCK HORMONE SIGNALING IN BREAST JRNL TITL 2 CANCER CELLS. JRNL REF NAT COMMUN V. 9 250 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 29343827 JRNL DOI 10.1038/S41467-017-02293-7 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_1631 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 11883 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.970 REMARK 3 FREE R VALUE TEST SET COUNT : 710 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.1604 - 4.4449 0.99 2323 138 0.1603 0.2154 REMARK 3 2 4.4449 - 3.5284 0.99 2224 169 0.1677 0.2411 REMARK 3 3 3.5284 - 3.0825 0.99 2248 107 0.2129 0.2740 REMARK 3 4 3.0825 - 2.8007 0.98 2202 142 0.2389 0.3012 REMARK 3 5 2.8007 - 2.6000 0.98 2176 154 0.2507 0.3530 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3171 REMARK 3 ANGLE : 1.308 4321 REMARK 3 CHIRALITY : 0.048 484 REMARK 3 PLANARITY : 0.006 555 REMARK 3 DIHEDRAL : 15.932 1193 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 8.9940 -16.4249 -26.9251 REMARK 3 T TENSOR REMARK 3 T11: 0.1863 T22: 0.1326 REMARK 3 T33: 0.1696 T12: -0.0630 REMARK 3 T13: 0.0207 T23: -0.0176 REMARK 3 L TENSOR REMARK 3 L11: 1.2025 L22: 0.5545 REMARK 3 L33: 0.9405 L12: -0.0429 REMARK 3 L13: -0.1663 L23: 0.1010 REMARK 3 S TENSOR REMARK 3 S11: 0.0690 S12: -0.1336 S13: 0.0125 REMARK 3 S21: 0.1186 S22: -0.0608 S23: 0.0945 REMARK 3 S31: 0.0174 S32: 0.0273 S33: 0.0003 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5NWH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-MAY-17. REMARK 100 THE DEPOSITION ID IS D_1200003160. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 46.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3AC9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26 MG/ML IN 0.1 M HEPES, PH 7.5, 300 REMARK 280 MM NACL, 10% GLYCEROL, AND 1 MM TCEP, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z+1/2 REMARK 290 4555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 29.63277 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.07300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 47.75982 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 29.63277 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.07300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 47.75982 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 SER A 3 REMARK 465 GLN A 4 REMARK 465 GLU A 5 REMARK 465 PRO A 6 REMARK 465 THR A 7 REMARK 465 GLU A 8 REMARK 465 SER A 9 REMARK 465 SER A 10 REMARK 465 GLN A 11 REMARK 465 ASN A 12 REMARK 465 GLY A 13 REMARK 465 PRO A 162 REMARK 465 GLY A 163 REMARK 465 ALA A 209 REMARK 465 LYS A 210 REMARK 465 PRO A 211 REMARK 465 PHE A 212 REMARK 465 GLU A 213 REMARK 465 VAL A 214 REMARK 465 PRO A 215 REMARK 465 PHE A 216 REMARK 465 LEU A 217 REMARK 465 LYS A 218 REMARK 465 PHE A 219 REMARK 465 MET B 1 REMARK 465 GLU B 2 REMARK 465 SER B 3 REMARK 465 GLN B 4 REMARK 465 GLU B 5 REMARK 465 PRO B 6 REMARK 465 THR B 7 REMARK 465 GLU B 8 REMARK 465 SER B 9 REMARK 465 SER B 10 REMARK 465 GLN B 11 REMARK 465 ASN B 12 REMARK 465 GLY B 13 REMARK 465 ALA B 209 REMARK 465 LYS B 210 REMARK 465 PRO B 211 REMARK 465 PHE B 212 REMARK 465 GLU B 213 REMARK 465 VAL B 214 REMARK 465 PRO B 215 REMARK 465 PHE B 216 REMARK 465 LEU B 217 REMARK 465 LYS B 218 REMARK 465 PHE B 219 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 57 O ALA A 59 1.77 REMARK 500 OH TYR B 74 O HOH B 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 56 CA - CB - CG ANGL. DEV. = 24.4 DEGREES REMARK 500 PRO A 158 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 GLU A 189 CB - CA - C ANGL. DEV. = -16.5 DEGREES REMARK 500 GLU A 189 N - CA - C ANGL. DEV. = 23.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 54 156.60 176.91 REMARK 500 ASP A 133 70.26 -158.64 REMARK 500 LEU A 136 -33.06 -141.80 REMARK 500 PRO A 160 74.11 -65.29 REMARK 500 ASP A 177 28.00 -145.80 REMARK 500 LYS B 55 -86.58 -127.53 REMARK 500 ASP B 133 68.27 -158.84 REMARK 500 LEU B 136 -30.09 -142.64 REMARK 500 ASP B 164 -70.23 -55.69 REMARK 500 ASP B 177 31.34 -147.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9CH A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9CH A 302 DBREF 5NWH A 1 219 UNP Q9UKK9 NUDT5_HUMAN 1 219 DBREF 5NWH B 1 219 UNP Q9UKK9 NUDT5_HUMAN 1 219 SEQRES 1 A 219 MET GLU SER GLN GLU PRO THR GLU SER SER GLN ASN GLY SEQRES 2 A 219 LYS GLN TYR ILE ILE SER GLU GLU LEU ILE SER GLU GLY SEQRES 3 A 219 LYS TRP VAL LYS LEU GLU LYS THR THR TYR MET ASP PRO SEQRES 4 A 219 THR GLY LYS THR ARG THR TRP GLU SER VAL LYS ARG THR SEQRES 5 A 219 THR ARG LYS GLU GLN THR ALA ASP GLY VAL ALA VAL ILE SEQRES 6 A 219 PRO VAL LEU GLN ARG THR LEU HIS TYR GLU CYS ILE VAL SEQRES 7 A 219 LEU VAL LYS GLN PHE ARG PRO PRO MET GLY GLY TYR CYS SEQRES 8 A 219 ILE GLU PHE PRO ALA GLY LEU ILE ASP ASP GLY GLU THR SEQRES 9 A 219 PRO GLU ALA ALA ALA LEU ARG GLU LEU GLU GLU GLU THR SEQRES 10 A 219 GLY TYR LYS GLY ASP ILE ALA GLU CYS SER PRO ALA VAL SEQRES 11 A 219 CYS MET ASP PRO GLY LEU SER ASN CYS THR ILE HIS ILE SEQRES 12 A 219 VAL THR VAL THR ILE ASN GLY ASP ASP ALA GLU ASN ALA SEQRES 13 A 219 ARG PRO LYS PRO LYS PRO GLY ASP GLY GLU PHE VAL GLU SEQRES 14 A 219 VAL ILE SER LEU PRO LYS ASN ASP LEU LEU GLN ARG LEU SEQRES 15 A 219 ASP ALA LEU VAL ALA GLU GLU HIS LEU THR VAL ASP ALA SEQRES 16 A 219 ARG VAL TYR SER TYR ALA LEU ALA LEU LYS HIS ALA ASN SEQRES 17 A 219 ALA LYS PRO PHE GLU VAL PRO PHE LEU LYS PHE SEQRES 1 B 219 MET GLU SER GLN GLU PRO THR GLU SER SER GLN ASN GLY SEQRES 2 B 219 LYS GLN TYR ILE ILE SER GLU GLU LEU ILE SER GLU GLY SEQRES 3 B 219 LYS TRP VAL LYS LEU GLU LYS THR THR TYR MET ASP PRO SEQRES 4 B 219 THR GLY LYS THR ARG THR TRP GLU SER VAL LYS ARG THR SEQRES 5 B 219 THR ARG LYS GLU GLN THR ALA ASP GLY VAL ALA VAL ILE SEQRES 6 B 219 PRO VAL LEU GLN ARG THR LEU HIS TYR GLU CYS ILE VAL SEQRES 7 B 219 LEU VAL LYS GLN PHE ARG PRO PRO MET GLY GLY TYR CYS SEQRES 8 B 219 ILE GLU PHE PRO ALA GLY LEU ILE ASP ASP GLY GLU THR SEQRES 9 B 219 PRO GLU ALA ALA ALA LEU ARG GLU LEU GLU GLU GLU THR SEQRES 10 B 219 GLY TYR LYS GLY ASP ILE ALA GLU CYS SER PRO ALA VAL SEQRES 11 B 219 CYS MET ASP PRO GLY LEU SER ASN CYS THR ILE HIS ILE SEQRES 12 B 219 VAL THR VAL THR ILE ASN GLY ASP ASP ALA GLU ASN ALA SEQRES 13 B 219 ARG PRO LYS PRO LYS PRO GLY ASP GLY GLU PHE VAL GLU SEQRES 14 B 219 VAL ILE SER LEU PRO LYS ASN ASP LEU LEU GLN ARG LEU SEQRES 15 B 219 ASP ALA LEU VAL ALA GLU GLU HIS LEU THR VAL ASP ALA SEQRES 16 B 219 ARG VAL TYR SER TYR ALA LEU ALA LEU LYS HIS ALA ASN SEQRES 17 B 219 ALA LYS PRO PHE GLU VAL PRO PHE LEU LYS PHE HET 9CH A 301 33 HET 9CH A 302 33 HETNAM 9CH 7-[[5-(3,4-DICHLOROPHENYL)-1,3,4-OXADIAZOL-2- HETNAM 2 9CH YL]METHYL]-1,3-DIMETHYL-8-PIPERAZIN-1-YL-PURINE-2,6- HETNAM 3 9CH DIONE FORMUL 3 9CH 2(C20 H20 CL2 N8 O3) FORMUL 5 HOH *46(H2 O) HELIX 1 AA1 THR A 104 GLY A 118 1 15 HELIX 2 AA2 ASP A 177 ALA A 187 1 11 HELIX 3 AA3 ASP A 194 ASN A 208 1 15 HELIX 4 AA4 THR B 104 GLY B 118 1 15 HELIX 5 AA5 ASP B 177 GLU B 189 1 13 HELIX 6 AA6 ASP B 194 ALA B 207 1 14 SHEET 1 A 3 THR A 43 ARG A 51 0 SHEET 2 A 3 VAL A 29 MET A 37 -1 SHEET 3 A 3 TYR A 16 LEU A 22 -1 SHEET 1 B 4 PRO A 95 LEU A 98 0 SHEET 2 B 4 GLY A 61 GLN A 69 -1 SHEET 3 B 4 THR A 140 ASN A 149 1 SHEET 4 B 4 ALA A 129 CYS A 131 -1 SHEET 1 C 3 PRO A 66 LEU A 68 0 SHEET 2 C 3 CYS A 76 GLN A 82 -1 SHEET 3 C 3 VAL A 168 PRO A 174 -1 SHEET 1 D 3 VAL A 80 ARG A 84 0 SHEET 2 D 3 GLY A 89 GLU A 93 -1 SHEET 3 D 3 LEU A 191 VAL A 193 1 SHEET 1 E 2 ASP A 122 CYS A 126 0 SHEET 2 E 2 VAL A 144 THR A 147 -1 SHEET 1 F 3 THR B 43 ARG B 51 0 SHEET 2 F 3 VAL B 29 MET B 37 -1 SHEET 3 F 3 TYR B 16 LEU B 22 -1 SHEET 1 G 4 PRO B 95 LEU B 98 0 SHEET 2 G 4 GLY B 61 GLN B 69 -1 SHEET 3 G 4 THR B 140 ASN B 149 1 SHEET 4 G 4 ALA B 129 CYS B 131 -1 SHEET 1 H 3 PRO B 66 LEU B 68 0 SHEET 2 H 3 CYS B 76 LYS B 81 -1 SHEET 3 H 3 GLU B 169 PRO B 174 -1 SHEET 1 I 2 VAL B 80 ARG B 84 0 SHEET 2 I 2 GLY B 89 GLU B 93 -1 SHEET 1 J 2 ASP B 122 CYS B 126 0 SHEET 2 J 2 VAL B 144 THR B 147 -1 SITE 1 AC1 9 TRP A 28 ARG A 51 ARG A 84 LEU A 98 SITE 2 AC1 9 CYS A 139 ILE A 141 HOH A 409 THR B 45 SITE 3 AC1 9 GLU B 47 SITE 1 AC2 8 THR A 45 TRP A 46 GLU A 47 TRP B 28 SITE 2 AC2 8 ARG B 51 ARG B 84 CYS B 139 ILE B 141 CRYST1 100.561 40.146 104.064 90.00 113.38 90.00 I 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009944 0.000000 0.004299 0.00000 SCALE2 0.000000 0.024909 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010469 0.00000